|
|
| CPT1B_RAT |
Cpt1b |
Carnitine O-palmitoyltransferase 1, muscle isoform |
9.163e-22 |
1.00
|
| ABC3A_HUMAN |
APOBEC3A |
DNA dC->dU-editing enzyme APOBEC-3A |
0.005858 |
1.00
|
| ABC3G_HUMAN |
APOBEC3G |
DNA dC->dU-editing enzyme APOBEC-3G |
0.04912 |
1.00
|
| CTDS1_HUMAN |
CTDSP1 |
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 |
0.09982 |
1.00
|
| CP1A2_HUMAN |
CYP1A2 |
Cytochrome P450 1A2 |
0.7151 |
1.00
|
| SL9A1_RAT |
Slc9a1 |
Sodium/hydrogen exchanger 1 |
6.286e-76 |
0.50
|
| S29A2_RAT |
Slc29a2 |
Equilibrative nucleoside transporter 2 |
6.927e-38 |
0.29
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
6.643e-34 |
0.37
|
| TPPP_BOVIN |
TPPP |
Tubulin polymerization-promoting protein |
2.127e-26 |
0.33
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
1.11e-20 |
0.37
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
2.22e-16 |
0.59
|
| 5HT6R_HUMAN |
HTR6 |
5-hydroxytryptamine receptor 6 |
6.883e-15 |
0.40
|
| CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
1.299e-14 |
0.59
|
| Q9JKC1_RAT |
Bche |
Carboxylic ester hydrolase |
3.919e-12 |
0.40
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
5.394e-12 |
0.37
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
2.964e-11 |
0.38
|
| HIF1A_HUMAN |
HIF1A |
Hypoxia-inducible factor 1-alpha |
2.56e-10 |
0.38
|
| RAC1_HUMAN |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
1.087e-09 |
0.28
|
| ACVR1_HUMAN |
ACVR1 |
Activin receptor type-1 |
1.042e-08 |
0.36
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
2.785e-08 |
0.33
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
4.015e-08 |
0.40
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
5.363e-08 |
0.28
|
| CAC1B_RAT |
Cacna1b |
Voltage-dependent N-type calcium channel subunit alpha-1B |
1.06e-07 |
0.59
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
1.496e-07 |
0.36
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.503e-07 |
0.40
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
4.789e-07 |
0.36
|
| PLPL6_MOUSE |
Pnpla6 |
Neuropathy target esterase |
7.69e-07 |
0.29
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
8.148e-07 |
0.48
|
| ACES_RAT |
Ache |
Acetylcholinesterase |
9.452e-07 |
0.31
|
| PTGDS_MOUSE |
Ptgds |
Prostaglandin-H2 D-isomerase |
1.255e-06 |
0.34
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
1.48e-06 |
0.30
|
| FGFR3_HUMAN |
FGFR3 |
Fibroblast growth factor receptor 3 |
1.54e-06 |
0.32
|
| 5HT1B_RAT |
Htr1b |
5-hydroxytryptamine receptor 1B |
1.808e-06 |
0.40
|
| MTLR_HUMAN |
MLNR |
Motilin receptor |
1.828e-06 |
0.33
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
1.944e-06 |
0.37
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
2.204e-06 |
0.40
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
2.253e-06 |
0.48
|
| BMR1A_HUMAN |
BMPR1A |
Bone morphogenetic protein receptor type-1A |
3.022e-06 |
0.33
|
| DPOL_VACCW |
POL |
DNA polymerase |
3.637e-06 |
0.30
|
| EBP_CAVPO |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
6.525e-06 |
0.35
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
7.445e-06 |
0.36
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
7.927e-06 |
0.36
|